Organization · Venture Capital
Sunstone Life Science Ventures
Sunstone Life Science Ventures is a Copenhagen-based venture capital firm specializing in early-stage investments in life science therapeutics across Europe. The firm focuses on drug development opportunities that improve patient outcomes.
Overview
What Sunstone Life Science Ventures does
What Sunstone Life Science Ventures is
Sunstone Life Science Ventures is a Copenhagen-based venture capital firm specializing in early-stage investments in life science therapeutics across Europe. The firm focuses on drug development opportunities that improve patient outcomes.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2007
- Approximate age
- About 19 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 31, 2026
Official channels
Find Sunstone Life Science Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sunstone Life Science Ventures as a funder
Investment thesis
Sunstone Life Science Ventures focuses on early-stage life science therapeutics, investing in companies developing novel drugs that address unmet medical needs, particularly in oncology and specialty pharmaceuticals.
Focus narrative
The firm invests primarily in early-stage life science companies that are developing novel therapeutics for humans, typically during the pre-clinical or clinical phase I stages. Sunstone's investment strategy targets opportunities that address unmet medical needs, particularly in niche markets such as specialty pharmaceuticals and orphan drug indications, with a keen interest in oncology.
Value beyond capital
Sunstone Life Science Ventures adds value to its portfolio companies through a long-term partnership model, providing not only capital but also strategic guidance and support in navigating the complexities of drug development. The firm leverages its extensive network and expertise in the life sciences sector to help companies achieve their goals and improve patient outcomes.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 201
- Recorded notable exits
- Santaris Pharma A/S
Portfolio context
Sunstone Life Science Ventures has invested in over 45 life science companies, including notable firms such as: Zymenex A/S: Developed Lamzede®, an enzyme replacement therapy for alpha-mannosidosis. Zealand Pharma A/S: Known for Lyxumia® (lixisenatide) and Zegalogue® (dasiglucagon). JenaValve Technology GmbH: Specializes in minimally-invasive heart valve replacement systems. Acarix AB: Markets the CADScor®System for cardiac screening. Prexton Therapeutics BV: Developed Foliglurax for Parkinson’s disease treatment. Santaris Pharma A/S: Focused on oligonucleotide therapeutics, acquired by Roche.
Capability profile
Sunstone Life Science Ventures as a publisher
Editorial focus
Sunstone Life Science Ventures specializes in early-stage investments in life science companies developing novel therapeutics. The firm primarily invests during the pre-clinical or clinical phase I stages, targeting opportunities that address unmet medical needs in niche markets such as specialty pharmaceuticals and orphan drug indications, with a strong emphasis on oncology.
Audience value
Sunstone Life Science Ventures aims to turn scientific discoveries into products that enhance patient outcomes while creating value for innovators, investors, and healthcare systems globally.
Format and cadence
- Content formats
- blog
- Primary platform
- Website
- Cadence
- regular updates
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors
- Sectors
- Biotech & Life Sciences
- Regions
- Europe
Flagship work and coverage
Flagship properties
Sunstone Life Science Ventures publishes insights and news articles on its website, including regular updates on portfolio companies and industry trends under the section 'News & Insights'.
Common questions
What to know about Sunstone Life Science Ventures
Upseed classifies Sunstone Life Science Ventures under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.